Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Procedure",
"id" : "PriorBMTProcedureExample",
"meta" : {
"profile" : [
🔗 "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-prior-bmt-procedure"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Prior autologous peripheral blood stem cell transplant after melphalan conditioning for multiple myeloma</p></div>"
},
"extension" : [
{
"url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-bmt-type-extension",
"valueCode" : "AUTOLOGOUS"
}
],
"status" : "completed",
"category" : {
"coding" : [
{
"system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
"code" : "SHA-BMT-AUTOLOGOUS",
"display" : "SHA: BMT — Autologous"
}
]
},
"code" : {
"coding" : [
{
"system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
"code" : "SHA-BMT-AUTOLOGOUS",
"display" : "SHA: BMT — Autologous"
}
]
},
"subject" : {
🔗 "reference" : "Patient/example-patient"
},
"performedDateTime" : "2022-08-20",
"note" : [
{
"text" : "High-dose melphalan 200 mg/m² conditioning. Day 0 stem cell infusion 15 Aug 2022. Engraftment day +12."
}
]
}